Medicare Enrolled
Dr. Jordan Buess, M.D.
Internal Medicine · Tyler, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Buess from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Buess?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Buess
Dr. Jordan Buess is an internal medicine specialist in Tyler, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Buess performed 33,207 Medicare services across 1,333 unique beneficiaries.
Between the years covered by Open Payments, Dr. Buess received a total of $3,135 from 39 pharmaceutical and/or device companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Buess is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 1% volume in TX
$3,135 industry payments
Medicare Practice Summary
Medicare Utilization ↗33,207
Medicare services
Top 1% in TX for internal medicine
1,333
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,690 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
7,140 | $0 | $5 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
6,500 | $0 | $33 |
| Pembrolizumab injection (Keytruda) | 6,000 | $44 | $139 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,200 | $0 | $2 |
| Paclitaxel chemotherapy injection | 3,152 | $0 | $8 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
1,290 | $35 | $235 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,033 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 960 | $19 | $68 |
| Injection, granisetron hydrochloride, 100 mcg | 320 | $0 | $24 |
| Injection, leucovorin calcium, per 50 mg | 292 | $4 | $25 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
247 | $12 | $108 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
184 | $2 | $13 |
| Anti-nausea injection (Aloxi/palonosetron) | 180 | $1 | $114 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
166 | $98 | $707 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 117 | $3 | $373 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
116 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
110 | $10 | $64 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
106 | $7 | $36 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
100 | $6 | $431 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
88 | $2 | $300 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
78 | $22 | $157 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
71 | $48 | $313 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
62 | $1 | $7 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
58 | $1 | $6 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
48 | $11 | $96 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
47 | $21 | $161 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
46 | $55 | $211 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $137 | $496 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $49 | $344 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 38 | $366 | $1,722 |
| Iron level test | 29 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
29 | $8 | $35 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
28 | $13 | $60 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
28 | $6 | $31 |
| New patient office visit, complex (60-74 min) | 28 | $168 | $709 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
26 | $1 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
26 | $2 | $19 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
25 | $16 | $100 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
20 | $124 | $500 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
19 | $7 | $29 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
19 | $4 | $23 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
18 | $15 | $94 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
15 | $15 | $76 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
15 | $42 | $289 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $120 | $565 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $98 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $62 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.7% high complexity
71.4% medium
1.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,135
Total received (2020-2024)
Avg $627/year across 5 years
Top 23% in TX for internal medicine
39
Companies
103
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,175 (69.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$960 (30.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,899
2023
$589
2022
$148
2021
$235
2020
$264
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$364
ABBVIE INC.
$282
AstraZeneca Pharmaceuticals LP
$239
Astellas Pharma US Inc
$221
Seagen Inc.
$214
Tempus AI, Inc
$182
Incyte Corporation
$127
Pharmacosmos Therapeutics Inc.
$126
Amgen Inc.
$124
Pharmacyclics LLC, An AbbVie Company
$112
Daiichi Sankyo Inc.
$97
GENZYME CORPORATION
$93
SANOFI-AVENTIS U.S. LLC
$91
SOBI, INC
$73
Rigel Pharmaceuticals, Inc.
$70
Alexion Pharmaceuticals, Inc.
$60
GlaxoSmithKline, LLC.
$48
E.R. Squibb & Sons, L.L.C.
$45
Novartis Pharmaceuticals Corporation
$41
PFIZER INC.
$41
Janssen Biotech, Inc.
$39
Genmab U.S., Inc.
$37
Celgene Corporation
$36
ARRAY BIOPHARMA INC
$33
Blueprint Medicines Corporation
$33
Immunocore Limited
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$28
Aveo Pharmaceuticals, Inc.
$28
Regeneron Healthcare Solutions, Inc.
$27
Stemline Therapeutics Inc.
$26
G1 Therapeutics, Inc.
$24
Sobi, Inc
$21
BeiGene USA, Inc.
$21
Adaptive Biotechnologies Corporation
$17
Sumitomo Pharma America, Inc.
$17
Genentech USA, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$13
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 28.2% of total payments
Associated products mentioned in payments ›
AYVAKIT · BOSULIF · BRUKINSA · COSELA · CYRAMZA · DOPTELET · ELREXFIO · ENHERTU · EPKINLY · Enhertu · Epkinly · FOTIVDA · GAMIFANT · IMBRUVICA · IMFINZI · IMJUDO · JEMPERLI · KIMMTRAK · KISQALI · LIBTAYO · LORBRENA · Lunsumio · MONJUVI · MONOFERRIC · Nubeqa · OJJAARA · ORGOVYX · Orserdu · Padcev · REBLOZYL · RETEVMO · SARCLISA · Stivarga · TECVAYLI · TUKYSA · Tavalisse · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · XALKORI · XARELTO · XT CDX · Xospata · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
170
Per 100K population
71.4
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Buess is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Buess experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Buess performed 7,140 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Buess receive payments from pharmaceutical companies?
Yes. Dr. Buess received a total of $3,135 from 39 companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Buess's costs compare to other internal medicine physicians in Tyler?
Dr. Buess's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Buess) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Tyler
Browse internal medicine physicians in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology